Promega Maxwell® 16 IVD System CE Marked to the European Union IVD Directive...
Promega Maxwell® 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious Disease
MADISON, WISCONSIN (March 18, 2010)
Maxwell® 16 IVD and Viral TNA System from Promega Corporation
The Promega Maxwell® 16 IVD System is CE marked in accordance with the requirements of Directive 98/79/EC on in vitro diagnostic medical devices. The CE mark applies to the instrument, the Maxwell® 16 Blood DNA Purification System and the Maxwell® 16 Viral Total Nucleic Acid Purification System. The bench top automation system is fully compliant with the IVD Directive and supports European clinical laboratories performing diagnostic tests in molecular pathology, transplant HLA, and Infectious disease.
The Maxwell 16 IVD System works to the specific needs of a clinical lab. Addressing the pressure to deliver quick results, especially in the process to determine organ compatibility or to diagnose infectious disease, Maxwell extracts multiple samples faster than manual methods. Up to 16 samples can be purified simultaneously, without user intervention and with higher yield and greater consistency. The unique design of Maxwell® 16 prevents cross contamination. The Maxwell 16 IVD includes integrated bar code reading to help reduce transcription errors, a UV lamp to assist in sanitization of the unit and its compact enough to operate inside a bio-safety cabinet.
"Enabling technologies like the Maxwell 16 can make a meaningful difference in clinical labs that face the accelerated demands of healthcare," explains Ashley Anderson M.D., Promega Chief Medical Officer, "Labs have told us repeatedly how quickly and accurately they can deliver life saving information and how easy it is to train new technicians. For some it's actually advanced the services they offer."
The new Maxwell 16 IVD System extracts DNA from whole or fractionated blood using the Maxwell 16 Blood DNA Purification System, or viral nucleic acid from plasma or serum samples using the Maxwell 16 Viral Total Nucleic Acid Purification System. The extracted nucleic acids are then used in standard amplification-based diagnostic assays conducted by European clinical labs. The system is fully integrated with pre-filled instrument cartridges and pre-programmed protocols. For more information on Maxwell, please visit www.maxwell-16.com.
About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.
These pages contain communications on Promega product releases and corporate activities. For additional new product information, see the new products page or the specific product or application area.
For more information about a new release article or about Promega in general, contact Penny Patterson at 1-608-274-4330 or complete this form.